ION464 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
17多系統萎縮症1

17. 多系統萎縮症


臨床試験数 : 119 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04165486
(ClinicalTrials.gov)
July 21, 202214/11/2019Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION464 Administered Intrathecally to Adults With Multiple System AtrophyMultiple System AtrophyDrug: ION464;Drug: PlaceboIonis Pharmaceuticals, Inc.NULLRecruiting40 Years70 YearsAll40Phase 1Austria;France;Germany;United Kingdom;Portugal